J&J vaccine blood clots, side effects detected in PA woman
NorthJersey.com One of the six women who developed an extremely rare blood clotting disorder after receiving the Johnson & Johnson COVID-19 vaccine is a 26-year-old gym instructor from the New Jersey-Pennsylvania area, the pharmaceutical company told a federal advisory committee Wednesday. Described as “overweight, but active,” the woman spent a week to 10 days in the hospital before being discharged with a prescription for anticoagulant medication, Dr. Aran Maree, the chief medical officer for the Janssen Pharmaceutical Companies of Johnson & Johnson, told the Advisory Committee...